Delorbis Pharmaceuticals Ltd is a leading European pharmaceutical company based in Cyprus, EU, specialising in the supply of a broad portfolio of branded medicines across the globe. The company is at the forefront of the pharmaceutical industry, focusing on the development and distribution of generics and biosimilars, notably through its extensive range of finished dosage forms. Delorbis is aggressively expanding its presence in new markets in Europe, the Middle East, and Asia, leveraging a combination of sales, marketing, business development activities, and fruitful partnerships to deliver best-in-class medicines for better and affordable healthcare.

Services include:
– Finished Dosage Forms
– Generics
– Biosimilars
– Contract Manufacturing
– Quality Assurance and Control

Delorbis Pharmaceuticals Ltd remains committed to providing innovative healthcare solutions while ensuring accessibility and affordability for patients. For more information, visit delorbispharma.eu.